10,753
Total Publications
598,372
Total Citations
Top Researchers
- Robert F. Storey 93,328 citations • 697 papers
- Christopher R. Chapple 40,772 citations • 1413 papers
- Edward M. Sellers 38,351 citations • 519 papers
- Ben S. Cooper 31,298 citations • 344 papers
- Simon S. Cross 30,586 citations • 630 papers
- R. Houston Thompson 25,581 citations • 73 papers
- Thomas S. Harrison 25,337 citations • 352 papers
- David S. Sanders 24,566 citations • 570 papers
- David G. Kiely 24,100 citations • 495 papers
- Michael J. Cork 23,005 citations • 400 papers
Most Cited Papers
- COVID-19: consider cytokine storm syndromes and immunosuppression 2020 • 10,131 citations
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK 2020 • 4,987 citations
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus 2020 • 4,460 citations
- Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments 2010 • 2,590 citations
- 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension 2022 • 1,944 citations
- Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial 2015 • 1,883 citations
- WFH Guidelines for the Management of Hemophilia, 3rd edition 2020 • 1,825 citations
- Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors 2016 • 1,535 citations
- Severe Hypoglycemia and Risks of Vascular Events and Death 2010 • 1,461 citations
- Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial 2016 • 1,290 citations